We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Gottlieb Flags FDA’s Plans for Generics in Senate Appropriations Hearing
Gottlieb Flags FDA’s Plans for Generics in Senate Appropriations Hearing
Generic drug approvals were in the spotlight during remarks by FDA Commissioner Scott Gottlieb before a Senate appropriations subcommittee on the FDA’s fiscal year 2019 budget request.